|
|
Volumn 38, Issue 5, 2009, Pages 272-276
|
|
Treatment approaches to irritable bowel syndrome.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DRUG DERIVATIVE;
GASTROINTESTINAL AGENT;
LOPERAMIDE;
LUBIPROSTONE;
MELATONIN;
PROBIOTIC AGENT;
PROSTAGLANDIN E1;
TRICYCLIC ANTIDEPRESSANT AGENT;
ARTICLE;
BEHAVIOR THERAPY;
CHILD;
CLINICAL TRIAL;
COGNITIVE THERAPY;
DIETARY FIBER;
HUMAN;
IRRITABLE COLON;
METHODOLOGY;
PEDIATRICS;
PHYSICIAN ATTITUDE;
PRESCHOOL CHILD;
PRIMARY HEALTH CARE;
TREATMENT OUTCOME;
ALPROSTADIL;
ANTI-BACTERIAL AGENTS;
ANTIDEPRESSIVE AGENTS, TRICYCLIC;
BEHAVIOR THERAPY;
CHILD;
CHILD, PRESCHOOL;
CLINICAL TRIALS AS TOPIC;
COGNITIVE THERAPY;
DIETARY FIBER;
GASTROINTESTINAL AGENTS;
HUMANS;
IRRITABLE BOWEL SYNDROME;
LOPERAMIDE;
MELATONIN;
PARASYMPATHOLYTICS;
PEDIATRICS;
PHYSICIAN'S ROLE;
PRIMARY HEALTH CARE;
PROBIOTICS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 67149107739
PISSN: 00904481
EISSN: None
Source Type: Journal
DOI: 10.3928/00904481-20090501-08 Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
